Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
FI: 4,122
Type: Article
Collaboration
Year: 2017
Writers
Alonso, S; Riveiro-Barciela, M; Fernandez, I; Rincon, D; Royal, AND; Llerena, S; Gea, F; Olveira, A; Fernandez-Carrillo, C; Pole, B; Carrion, J.A.; Gomez, A; Devesa, MJ; Baliellas, C; Castro, A; Ampuero, J; Granados, R; Pascasio, JM; Rubin, A; Salmeron, J; Badia, E; Planas, JMM; Lens, S; Turnes, J; Montero, JL; Buti, M; Stephen, R; Fernandez-Rodriguez, CM
Magazine
Title: JOURNAL OF VIRAL HEPATITIS
Quartile
- Q1